What is DSI?
DSI specializes in providing a comprehensive preclinical platform designed to assess physiological data from research animals. Their offerings include advanced telemetry systems, pulmonary solutions, integrated software platforms, and essential services, all aimed at enhancing the accuracy and depth of scientific research. Headquartered in St. Paul, Minnesota, DSI serves a critical role in the life sciences sector by equipping researchers with sophisticated tools for data acquisition and analysis.
How much funding has DSI raised?
DSI has raised a total of $12M across 1 funding round:
Series A
$12M
Series A (2002): $12M, investors not publicly disclosed
What's next for DSI?
The recent major strategic investment signals a pivotal moment for DSI, likely enabling expansion of its technological capabilities and market reach. This capital infusion is expected to fuel further innovation in physiological monitoring solutions for research animals, potentially leading to new product development and enhanced service offerings. DSI's focus on providing a complete preclinical platform positions it for continued growth and influence within the enterprise research community, as it seeks to deepen its impact on scientific discovery.
See full DSI company page
